Radiotherapy & Oncology
Volume 93, Issue 1 , Pages 14-17 , October 2009

Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer

  • Barbara A. Jereczek-Fossa

      Affiliations

    • Department of Radiotherapy, European Institute of Oncology, Milan, Italy
    • University of Milan, Milan, Italy
    • Corresponding Author InformationCorresponding author. Address: Department of Radiotherapy, European Institute of Oncology, via Ripamonti 435, Milan 20141, Italy.
    • ,
  • Laura Fariselli

      Affiliations

    • Cyberknife Center CDI, Milan, Italy
    • Radiotherapy Unit of the Carlo Besta Neurological Institute Foundation, Milan, Italy
    • ,
  • Giancarlo Beltramo

      Affiliations

    • Cyberknife Center CDI, Milan, Italy
    • ,
  • Gianpiero Catalano

      Affiliations

    • Department of Radiotherapy, European Institute of Oncology, Milan, Italy
    • ,
  • Flavia Serafini

      Affiliations

    • Department of Radiotherapy, European Institute of Oncology, Milan, Italy
    • ,
  • Cristina Garibaldi

      Affiliations

    • Department of Medical Physics, European Institute of Oncology, Milan, Italy
    • ,
  • Raffaella Cambria

      Affiliations

    • Department of Medical Physics, European Institute of Oncology, Milan, Italy
    • ,
  • Lorenzo Brait

      Affiliations

    • Cyberknife Center CDI, Milan, Italy
    • ,
  • Marco Possanzini

      Affiliations

    • Cyberknife Center CDI, Milan, Italy
    • ,
  • Livia C. Bianchi

      Affiliations

    • Cyberknife Center CDI, Milan, Italy
    • ,
  • Andrea Vavassori

      Affiliations

    • Department of Radiotherapy, European Institute of Oncology, Milan, Italy
    • ,
  • Dario Zerini

      Affiliations

    • Department of Radiotherapy, European Institute of Oncology, Milan, Italy
    • ,
  • Franco Orsi

      Affiliations

    • Unit of Interventional Radiology, European Institute of Oncology, Milan, Italy
    • ,
  • Ottavio de Cobelli

      Affiliations

    • Department of Urology, European Institute of Oncology, Milan, Italy
    • University of Milan, Milan, Italy
    • ,
  • Roberto Orecchia

      Affiliations

    • Department of Radiotherapy, European Institute of Oncology, Milan, Italy
    • University of Milan, Milan, Italy

Received 4 October 2008 ,Revised 26 March 2009 ,Accepted 4 April 2009.

References 

  1. Calcerrada Díaz-Santos N, Blasco Amaro JA, Cardiel GA, Andradas Aragonés E. The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature. Radiother Oncol. 2008;89:245–253
  2. Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30:637–644
  3. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  4. Dirix P, Haustermans K, Junius S, Withers R, Oyen R, Van Poppel H. The role of whole pelvic radiotherapy in locally advanced prostate cancer. Radiother Oncol. 2006;79:1–14
  5. Fransson P, Bergstrom P, Lofroth PO, Widmark A. Prospective evaluation of urinary and intestinal side effects after BeamCath® stereotactic dose-escalated radiotherapy of prostate cancer. Radiother Oncol. 2002;63:239–248
  6. Gibbs IC, Kamnerdsupaphon P, Ryu MR, et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol. 2007;82:185–190
  7. Gronau E, Goppelt M, Harzmann R, et al. Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma. Onkologie. 2005;28:361–366
  8. Iversen P, Roder MA. The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer. Expert Rev Anticancer Ther. 2008;8:361–369
  9. Jereczek-Fossa BA, Kowalczyk A, D’Onofrio A, et al. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients. Strahlenther Onkol. 2008;184:36–40
  10. Jereczek-Fossa BA, Orecchia R. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. Radiother Oncol. 2007;84:197–215
  11. Katz EE, Harding JN, Brendler C. Return of serum prostate specific antigen to undetectable level following removal of solitary lymph node metastasis. J Urol. 2002;168:2546
  12. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006;16:77–84
  13. Kim SH, Chao ST, Toms SA, et al. Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma. Surg Neurol. 2008;69:641–646
  14. Krause BJ, Souvatzoglou M, Tuncel M, et al. The detection rate of [11C]choline PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35:18–23
  15. Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys. 2007;67:1099–1105
  16. Miles EF, Lee WR. Hypofractionation for prostate cancer: a critical review. Semin Radiat Oncol. 2008;18:41–47
  17. Miralbell R, Molla M, Arnalte R, et al. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?. Int J Radiat Oncol Biol Phys. 2004;59:366–371
  18. Pawlicki T, Cotrutz C, King C. Prostate cancer therapy with stereotactic body radiation therapy. Front Radiat Ther Oncol. 2007;40:395–406
  19. Prostate cancer. In: National Comprehensive Cancer network Clinical Practice Guidelines in Oncology, version 1.2008. Jenkinstown, PA: National Comprehensive Cancer Network, March 2008. Available from: http://www.nccn.org/professionals/physician_gls/default.asp.
  20. Pruthi RS, Hubbard JS, Kouba E, Wallen E. Androgen-independent prostate cancer treated with resection of the solitary metastatic site. Urol Int. 2007;9:371–373
  21. Rubin P, Brasacchio R, Katz A. Solitary metastases: illusion versus reality. Semin Radiat Oncol. 2006;16:120–130
  22. Sakamoto N, Eto M, Ando S. Surgical excision of a metastatic adrenal lesion in a patient with prostatic cancer. Int J Urol. 1999;6:38–40
  23. Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA. 2004;291:1325–1332
  24. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25:947–952

PII: S0167-8140(09)00149-2

doi: 10.1016/j.radonc.2009.04.001

Radiotherapy & Oncology
Volume 93, Issue 1 , Pages 14-17 , October 2009

Article Tools